- Category
- Medium (2023-24)
- Udyam number
- UDYAM-AS-16-0001038

About Signova Pharma Private Limited
Data last updated:
Signova Pharma Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 January 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51397AS2008PTC008558. Its GSTIN is 18AAMCS2756E1Z4 (Assam). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹40 Lakh. It is led by directors Satrajit Kanungo and Ranjan Kumar Deka.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No – 44 Ground Floor Barthakur Mill Road Ulubari, Guwahati, Assam, India – 781007.
As per the financials filed for FY 2025, the company reported a revenue of ₹130.91 Cr. For the same year it recorded a net profit of ₹6.79 Cr (net margin 5.2%) and EBITDA of ₹11.66 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 16% over five years.
The company has about 546 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Signova Pharma. As per MCA filings, the company has open charges of ₹34.29 Cr and satisfied charges of ₹21.95 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 3 cases are pending. The company has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹1.03 Cr; the latest was in March 2016. Its 8 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 3 smaller; the largest is BLD Pharmatech (India) Private Limited with revenue of ₹137.25 Cr.
Signova Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0001038). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website signovapharma.com.
Company details
Recognitions & Rankings of Signova Pharma
Contact details
Signova Pharma Private Limited's registered office is in Guwahati, Assam. Its website is signovapharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressHouse No – 44 Ground Floor Barthakur Mill Road Ulubari, Guwahati, Assam, India – 781007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Signova Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Signova Pharma operates one associated brand: Signova Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical product development and distribution in healthcare. | signovapharma.com |
Business activity
The main business activity of Signova Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Signova Pharma Private Limited, buy the company report.
Financials of Signova Pharma Private Limited
FY 2024 filings availableSignova Pharma Private Limited reported revenue of ₹130.91 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Signova Pharma Private Limited, buy the company report.
Board of directors of Signova Pharma Private Limited
Signova Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satrajit Kanungo | Director | 04 Jan 2008 | 18 Years 10 Months | Current |
| Ranjan Kumar Deka Also directs: Signova Healthcare Private Limited, Signova Healthcare Unit III Private Limited, Seema Trade and Associates LLP and 5 more | Director | 04 Jan 2008 | 18 Years 10 Months | Current |
Peer comparison
Signova Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BLD Pharmatech (India) Private Limited | ₹137.25 Cr (FY 2025) | 23.0% | Hyderabad, Telangana, India | |||
| Surat Sales Pvt Ltd | ₹135.04 Cr (FY 2025) | 121.0% | Surat, Gujarat, India | |||
| Organon (India) Private Limited | ₹134.83 Cr (FY 2025) | 20.0% | Mumbai, Maharashtra, India | |||
| R.S. Surgipharm Private Limited | ₹134.47 Cr (FY 2025) | 32.0% | Gujarat, India | |||
| Shivanitin Agencies Private Limited | ₹132.83 Cr (FY 2025) | 50.0% | Dehradun, Uttarakhand, India | |||
| Signova Pharma Private Limitedthis company | ₹130.91 Cr (FY 2025) | ₹6.79 Cr | 5.2% | 546 | Guwahati, Assam, India | |
| Milton Lifecare Private Limited | ₹130.32 Cr (FY 2024) | 37.0% | Mumbai, Maharashtra, India | |||
| Oceanic Techno Chem Private Limited | ₹128.85 Cr (FY 2025) | 57.0% | Mumbai, Maharashtra, India | |||
| Vasavi Medicare Solutions Private Limited | ₹128.66 Cr (FY 2025) | 20.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Signova Pharma Private Limited, buy the company report.
Auditor
Signova Pharma Private Limited is audited by MANISH RAJKUMAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH RAJKUMAR & CO. | FY 2023 | 324945E |
Shareholding
The shareholding of Signova Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Signova Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Mar 2024 | 100881535 | Others | ₹19.99 Lakh | Open | |
| 15 Feb 2024 | 100871505 | Others | ₹16.11 Lakh | Open | |
| 15 Feb 2024 | 100871788 | Others | ₹17.01 Lakh | Open | |
| 27 Sep 2022 | 100641256 | Others | ₹33.76 Cr | Open | |
| 24 Nov 2021 | 100504321 | Axis Bank Limited | ₹1.6 Cr | Satisfied |
To see the full charge records of Signova Pharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Signova Pharma Private Limited has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹1.03 Cr; the latest was in March 2016.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Rights issue | ₹55 Lakh | Investors: an individual |
| Mar 2016 | Funding round | ₹55 Lakh | Investors: an individual |
| Jan 2013 | Funding round | ₹40 Lakh | Investors: 4 individuals |
| Sep 2009 | Funding round | ₹8 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Signova Pharma Private Limited has 7 court cases on record: 2 filed by Signova Pharma, 5 filed against it. 3 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 3 | 2 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Alkem Laboratories Ltd | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Alkem Laboratories Ltd | Pending |
| Bombay High Court | Court case (APP) | Filed by the company against Glenmark Pharmaceuticals Ltd and Anr and 1 other | Disposed |
| Bombay High Court | Court case (NMA) | Filed by the company against Glenmark Pharmaceuticals Ltd and Anr and 1 other | Disposed |
| District court, Kamrup Metro, Assam | Court case (Motor Vehicle Act) | Filed against the company by State of Assam | Pending |
To see the full case history of Signova Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Signova Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Signova Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Employees & EPFO
Signova Pharma Private Limited has a workforce of 546 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 546 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Signova Pharma Private Limited, buy the company report.
GST
Signova Pharma has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAMCS2756E1Z4 | Assam | Active | 01 Jul 2017 |
| 04AAMCS2756E1ZD | Chandigarh | Active | 01 Jul 2017 |
| 19AAMCS2756E1Z2 | West Bengal | Active | 02 Aug 2019 |
| 02AAMCS2756E1ZH | Himachal Pradesh | Active | 01 Sep 2021 |
To see the full GST registrations and return filing status of Signova Pharma Private Limited, buy the company report.
Recent activity
Signova Pharma Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Ranjan Kumar Deka was appointed as Director on 04 Jan 2008.
10 earlier events are in the company report.
Frequently asked questions
Signova Pharma is an active private limited company based in Guwahati, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 January 2008 (18+ years old) and is registered under CIN U51397AS2008PTC008558.
Signova Pharma has 2 current directors:
- Satrajit Kanungo - Director
- Ranjan Kumar Deka - Director
The latest financial statements of Signova Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Signova Pharma is 18AAMCS2756E1Z4, registered in Assam. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 04AAMCS2756E1ZD (Chandigarh), 19AAMCS2756E1Z2 (West Bengal), 02AAMCS2756E1ZH (Himachal Pradesh).
The CIN (Corporate Identification Number) of Signova Pharma is U51397AS2008PTC008558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Signova Pharma has 7 court cases on record: 2 filed by the company and 5 filed against it. 3 are pending. Most are in the high courts.
Signova Pharma was incorporated on 04 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Guwahati.
Signova Pharma has 4 deals on record (3 funding rounds, 1 rights issue), with disclosed funding of ₹1.03 Cr; the latest was in March 2016.
The peers of Signova Pharma by revenue are BLD Pharmatech (India) Private Limited, Surat Sales Pvt Ltd, Organon (India) Private Limited, R.S. Surgipharm Private Limited, Shivanitin Agencies Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ranjan Kumar Deka was appointed as Director on 04 Jan 2008. Satrajit Kanungo was appointed as Director on 04 Jan 2008.
Yes, Signova Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-AS-16-0001038).

